Literature DB >> 25263042

Efficacy and safety of pain relief medications after photorefractive keratectomy: review of prospective randomized trials.

Ella G Faktorovich1, Karishma Melwani2.   

Abstract

UNLABELLED: The objective of this review was to provide a comprehensive overview and comparison of results from all prospective randomized trials published to date of medications used to treat pain after photorefrative keratectomy (PRK). A PubMed database search revealed 23 prospective and randomized studies. They included the following classes of medications: nonsteroidal antiimflammatory drugs (NSAIDs), anesthetics, opiates, acetaminophen, gabapentin, and pregabalin. The studies found that although the efficacy of drugs tended to be similar, tetracaine 1% and nepafenac 0.1% tended to have the most analgesic effect. Delayed corneal reepithelialization was a common side effect of both topical anesthetics and topical NSAIDs. Tetracaine 1% resulted in the most significant delay in reepithelialization when tested against placebo control compared with other topical medications tested against placebo. Concomitant use of topical NSAIDs and topical anesthetics, especially tetracaine, may have to be avoided to minimize the risk for delayed corneal healing. FINANCIAL DISCLOSURE: Neither author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2014 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25263042     DOI: 10.1016/j.jcrs.2014.08.001

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  12 in total

Review 1.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 2.  Immunity and pain in the eye: focus on the ocular surface.

Authors:  Romina Mayra Lasagni Vitar; Filippo Bonelli; Paolo Rama; Giulio Ferrari
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

3.  Two-year stability of posterior corneal surface after transepithelial photorefractive keratectomy with a residual stromal thickness less than 350 μm.

Authors:  Hua Li; Jiafan Zhang; Ting Shao; Huifeng Wang; Sai Liu; Keli Long
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-23       Impact factor: 3.535

4.  The use of topical nalbuphine in different concentrations to control pain after photorefractive keratectomy.

Authors:  Hala Kamal Mattout; Sameh Mosaad Fouda
Journal:  Int Ophthalmol       Date:  2022-01-12       Impact factor: 2.029

Review 5.  Refractive surgery beyond 2020.

Authors:  Marcus Ang; Damien Gatinel; Dan Z Reinstein; Erik Mertens; Jorge L Alió Del Barrio; Jorge L Alió
Journal:  Eye (Lond)       Date:  2020-07-24       Impact factor: 3.775

6.  Ocular pain and discomfort after advanced surface ablation: an ignored complaint.

Authors:  Eva M Sobas; Sebastián Videla; Miguel J Maldonado; Jose C Pastor
Journal:  Clin Ophthalmol       Date:  2015-09-04

Review 7.  Chronic dry eye symptoms after LASIK: parallels and lessons to be learned from other persistent post-operative pain disorders.

Authors:  Alexandra E Levitt; Anat Galor; Jayne S Weiss; Elizabeth R Felix; Eden R Martin; Dennis J Patin; Konstantinos D Sarantopoulos; Roy C Levitt
Journal:  Mol Pain       Date:  2015-04-21       Impact factor: 3.395

8.  Ophthalmic nepafenac use in the Netherlands and Denmark.

Authors:  Andrea V Margulis; Eline Houben; Jesper Hallas; Jetty A Overbeek; Anton Pottegård; Tobias Torp-Pedersen; Susana Perez-Gutthann; Alejandro Arana
Journal:  Acta Ophthalmol       Date:  2017-05-10       Impact factor: 3.761

9.  Effects of Pranoprofen on Aqueous Humor Monocyte Chemoattractant Protein-1 Level and Pain Relief During Second-Eye Cataract Surgery.

Authors:  Yinglei Zhang; Yu Du; Yongxiang Jiang; Xiangjia Zhu; Yi Lu
Journal:  Front Pharmacol       Date:  2018-07-17       Impact factor: 5.810

10.  The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation.

Authors:  Dinesh Thapa; Elizabeth A Cairns; Anna-Maria Szczesniak; James T Toguri; Meggie D Caldwell; Melanie E M Kelly
Journal:  Cannabis Cannabinoid Res       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.